INDSWFTLTD vs KPL: Stock Comparison
Ind-Swift Limited vs Kwality Pharmaceuticals Ltd
Live data: 13 August 2025, 4:01 PM IST • Source: NSE and company filings
Ind-Swift Limited shows a higher net margin, while Kwality Pharmaceuticals Ltd shows a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Side-by-side comparison of Ind-Swift Limited and Kwality Pharmaceuticals Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | INDSWFTLTD | KPL |
|---|---|---|
| Sector | Healthcare | — |
| Industry | Pharmaceuticals | — |
Price
| Metric | INDSWFTLTD | KPL |
|---|---|---|
| Live Price | ₹15.76 | ₹2,590.4 |
| Day Change | 6.13% | -4.34% |
| Volume | 6.45 L | 26,342 |
| 52-Week High | ₹17.82 | ₹2,890.3 |
| 52-Week Low | ₹14.71 | ₹1,561 |
| Distance from 52W High | -11.56% | -10.38% |
Valuation
| Metric | INDSWFTLTD | KPL |
|---|---|---|
| Market Cap | ₹0 Cr | ₹2,692 Cr |
| P/E Ratio | — | 39.83x |
| P/B Ratio | — | 8.09x |
| EPS | ₹0 | ₹64.9 |
| Book Value | ₹-122 | ₹320 |
| Dividend Yield | 0% | 0% |
Growth
| Metric | INDSWFTLTD | KPL |
|---|---|---|
| Revenue Growth (TTM YoY) | 0% | 0% |
| EPS Growth (TTM YoY) | 0% | 0% |
| Qtr Sales Growth | 0% | 35.8% |
| Qtr Profit Growth | 0% | 74.6% |
Profitability & Leverage
| Metric | INDSWFTLTD | KPL |
|---|---|---|
| ROE | — | 22.8% |
| ROCE | 13.4% | 24.2% |
| Net Margin | 55.01% | 13.39% |
| Operating Margin | 63.48% | 23.5% |
| Debt to Equity | — | 0.39x |
Shareholding
As of Jun 2025 • change vs previous quarter| Metric | INDSWFTLTD | KPL |
|---|---|---|
| Promoter Holding | 55.58% | 54.87%▲ 0.04 pp |
| FII Holding | 0% | 2.79%▲ 2.29 pp |
| DII Holding | 0% | 0.36%▲ 0.03 pp |
| Public Holding | 44.42% | 41.98%▼ 2.36 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Ind-Swift Limited and Kwality Pharmaceuticals Ltd.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.